← All candidates
One insider bought $118.1K in three days.
30 filings on record.
INMInMed Pharmaceuticals Inc.
NasdaqCM · Healthcare · $7.47M
$1.36
-2.16% · Sep 18
One insider bought $118.1K in three days.
Led by ADAR1 Capital Management, LLC, 10% owner.
Price · 1Y · daily● 30 buys◆ 21 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 3×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what INM ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$7.47M
Float
1.4M
25% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.4
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
ADAR1 Capital Management, LLC
Bought $312.1K on May 19 — 200,000 sh @ $1.56, held indirect, 33% of their stake.
No completed positions to measure
10% owner
Vivo Opportunity, LLC
Bought $79.6K on May 20 — 51,056 sh @ $1.56, held indirect, 9.4% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
25 more transactions on Pro →Context
The file stays open
30 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice